Skip to main content

01.03.2011 | Original Article

Is Obesity a Risk Factor for Crohn’s Disease?

verfasst von: Michael A. Mendall, A. Viran Gunasekera, B. Joseph John, Devinder Kumar

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity is associated with a proinflammatory state.

Aim

To determine whether obesity at diagnosis is a risk factor for Crohn’s disease vs. ulcerative colitis and also vs. community controls and whether there is a U-shaped relationship between body mass index at diagnosis and risk of Crohn’s disease versus ulcerative colitis.

Methods

A total of 524 consecutive inflammatory bowel disease patients attending gastroenterology clinics were administered a questionnaire inquiring about weight at diagnosis and height as well as other risk factors for inflammatory bowel disease. An opportunistic control group of 480 community controls aged 50–70 were randomly selected from the registers of four local general practices as part of another study.

Results

Obesity at diagnosis was more common in subjects with Crohn’s disease versus ulcerative colitis odds ratio 2.02 (1.18–3.43) p = 0.0096 and also Crohn’s disease versus community controls in the 50–70 year age group (odds ratio 3.22 (1.59–6.52) p = 0.001). There was evidence of a ‘dose response’ with increasing degrees of obesity associated with increased risk. Low BMI at diagnosis was also associated with risk of Crohn’s disease versus ulcerative colitis. A U-shaped relationship between BMI and risk of Crohn’s was supported by the strong inverse association of BMI at diagnosis (p = 0.0001) and positive association of BMI at diagnosis squared (p = 0.0002) when they were fitted together into the model.

Conclusions

Obesity may play a role in the pathogenesis of Crohn’s disease and it may be that obesity-related enteropathy is a distinct entity or a sub-type of Crohn’s disease.
Literatur
1.
Zurück zum Zitat Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 1997;78:273–277.PubMed Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 1997;78:273–277.PubMed
2.
Zurück zum Zitat Delgado-Aros S, Locke GR 3rd, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol. 2004;99:1801–1806.CrossRefPubMed Delgado-Aros S, Locke GR 3rd, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol. 2004;99:1801–1806.CrossRefPubMed
3.
Zurück zum Zitat Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA. Bowel inflammation as measured by fecal calprotectin: A link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:279–284.CrossRefPubMed Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA. Bowel inflammation as measured by fecal calprotectin: A link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:279–284.CrossRefPubMed
4.
Zurück zum Zitat Brun P, Castagliuolo I, Di Leo V, et al. Increased intestinal permeability in obese mice: New evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2007;292:G518–G525.CrossRefPubMed Brun P, Castagliuolo I, Di Leo V, et al. Increased intestinal permeability in obese mice: New evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2007;292:G518–G525.CrossRefPubMed
5.
Zurück zum Zitat Timmer A. Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology. Dig Dis 2003;21:91–104. Timmer A. Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology. Dig Dis 2003;21:91–104.
6.
Zurück zum Zitat Karmiris K, Koutroubakis IE, Kouroumalis EA. The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:847–855.CrossRefPubMed Karmiris K, Koutroubakis IE, Kouroumalis EA. The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:847–855.CrossRefPubMed
7.
Zurück zum Zitat John BJPS, Mendall MA, et al.: Relation of obesity to late onset Crohn’s. Gut 2006;55:A74. John BJPS, Mendall MA, et al.: Relation of obesity to late onset Crohn’s. Gut 2006;55:A74.
8.
Zurück zum Zitat May S, Bigelow C. Modeling nonlinear dose-response relationships in epidemiologic studies: Statistical approaches and practical challenges. Dose Response. 2005;3:474–490.CrossRef May S, Bigelow C. Modeling nonlinear dose-response relationships in epidemiologic studies: Statistical approaches and practical challenges. Dose Response. 2005;3:474–490.CrossRef
9.
Zurück zum Zitat John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA. Systematic review: Adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006;23:1511–1523.CrossRefPubMed John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA. Systematic review: Adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006;23:1511–1523.CrossRefPubMed
10.
Zurück zum Zitat Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–1830.PubMed Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–1830.PubMed
11.
Zurück zum Zitat Charriere G, Cousin B, Arnaud E, et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem. 2003;278:9850–9855.CrossRefPubMed Charriere G, Cousin B, Arnaud E, et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem. 2003;278:9850–9855.CrossRefPubMed
12.
Zurück zum Zitat Karagiannides I, Kokkotou E, Tansky M, et al. Induction of colitis causes inflammatory responses in fat depots: Evidence for substance p pathways in human mesenteric preadipocytes. Proc Natl Acad Sci USA. 2006;103:5207–5212.CrossRefPubMed Karagiannides I, Kokkotou E, Tansky M, et al. Induction of colitis causes inflammatory responses in fat depots: Evidence for substance p pathways in human mesenteric preadipocytes. Proc Natl Acad Sci USA. 2006;103:5207–5212.CrossRefPubMed
13.
Zurück zum Zitat Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005;25:2062–2068.CrossRefPubMed Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol. 2005;25:2062–2068.CrossRefPubMed
14.
Zurück zum Zitat Suganami T, Tanimoto-Koyama K, Nishida J, et al. Role of the toll-like receptor 4/nf-kappab pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol. 2007;27:84–91.CrossRefPubMed Suganami T, Tanimoto-Koyama K, Nishida J, et al. Role of the toll-like receptor 4/nf-kappab pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol. 2007;27:84–91.CrossRefPubMed
15.
Zurück zum Zitat Peyrin-Biroulet L, Chamaillard M, Gonzalez F, Beclin E, Decourcelle C, Antunes L, Gay J, Neut C, Colombel JF, Desreumaux P. Mesenteric fat in Crohn’s disease: A pathogenetic hallmark or an innocent bystander? Gut. 2007 Apr;56(4):577–583 (Epub 2006 Sep 6, Review). Peyrin-Biroulet L, Chamaillard M, Gonzalez F, Beclin E, Decourcelle C, Antunes L, Gay J, Neut C, Colombel JF, Desreumaux P. Mesenteric fat in Crohn’s disease: A pathogenetic hallmark or an innocent bystander? Gut. 2007 Apr;56(4):577–583 (Epub 2006 Sep 6, Review).
Metadaten
Titel
Is Obesity a Risk Factor for Crohn’s Disease?
verfasst von
Michael A. Mendall
A. Viran Gunasekera
B. Joseph John
Devinder Kumar
Publikationsdatum
01.03.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1541-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.